GoodCell, a Waltham, Mass.-based company decoding human health to extend and improve the quality of life through technology, raised $17.9m in a equity funding.
The backers were not disclosed.
The company intends to use the funds to expand its development efforts and its business reach.
Led by Trevor Perry, Founder and Chief Executive Officer, and Brad Hamilton, Founder and Chief Science Officer, GoodCell has developed a platform that combines personal biobanking, diagnostics and data to provide individuals and their families with the ability to securely test, track and respond to health risks, while enabling the scientific community to advance diagnostics and drug development at scale to create next-generation safeguards for global health.
FinSMEs
26/10/2020